Related references
Note: Only part of the references are listed.Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
Gerald Raverot et al.
CLINICAL ENDOCRINOLOGY (2012)
Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly
Emilie Morin et al.
PITUITARY (2012)
Treatment of Pituitary Neoplasms With Temozolomide A Review
Luis V. Syro et al.
CANCER (2011)
Clinically silent somatotroph adenomas are common
Alisha N. Wade et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Pituitary Carcinoma: Difficult Diagnosis and Treatment
Anthony P. Heaney
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
Fateme Salehi et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Temozolomide-induced inhibition of pituitary adenoma cells Laboratory investigation
Jason Sheehan et al.
JOURNAL OF NEUROSURGERY (2011)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Possible role of a radiation-induced p53 mutation in a Nelson's syndrome patient with a fatal outcome
Emilia Modolo Pinto et al.
PITUITARY (2011)
MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern
Sayid Shafi Zuhur et al.
ENDOCRINE (2011)
Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
Marco Losa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation
Andrea G. Lania et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
MGMT immunoexpression in aggressive pituitary adenoma and carcinoma
Queenie Lau et al.
PITUITARY (2010)
The epidemiology and genetics of pituitary adenomas
Adrian F. Daly et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience
D. Erickson et al.
CLINICAL ENDOCRINOLOGY (2009)
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
Ann I. McCormack et al.
CLINICAL ENDOCRINOLOGY (2009)
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
C. Hagen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Modification of hormonal secretion in clinically silent pituitary adenomas
Tania Daems et al.
PITUITARY (2009)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemical approaches to the discovery and development of cancer therapies
S Neidle et al.
NATURE REVIEWS CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
